We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,929 results
  1. Metoprolol

    Reference work entry 2024
  2. Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug

    To investigate the pharmacokinetic and pharmacodynamic profiles of volunteers carrying CYP2D6 genotypes with unknow metabolic phenotypes, a total of...

    Jianchang Qian, Tao Xu, ... Jian** Cai in The Pharmacogenomics Journal
    Article 18 April 2024
  3. Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway

    Purpose

    To compare the co-prescription of metoprolol and potent CYP2D6-inhibiting antidepressants before and during a 10-year period after...

    Ane Gedde-Dahl, Olav Spigset, Espen Molden in European Journal of Clinical Pharmacology
    Article Open access 25 July 2022
  4. Early donepezil monotherapy or combination with metoprolol significantly prevents subsequent chronic heart failure in rats with reperfused myocardial infarction

    Despite the presence of clinical guidelines recommending that β-blocker treatment be initiated early after reperfused myocardial infarction (RMI),...

    Meihua Li, Can Zheng, ... Masaru Sugimachi in The Journal of Physiological Sciences
    Article Open access 20 June 2022
  5. Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis

    Cardiomyocyte senescence is involved in the pathological mechanism of cardiac diseases. Metoprolol is a β1 receptor blocker used for the treatment of...

    Qiang Li, Kang Huang, ... Jianghua Zhong in Cardiovascular Toxicology
    Article Open access 20 November 2021
  6. Synthesis, Characterization, In Silico Analysis, and Pharmacological Evaluation of Metoprolol-Modified Saccharide Conjugates for Cardiovascular Targeting

    Targeted drug delivery to selective cell has emerged as one of the most significant areas of biomedical engineering research today, so to optimize...

    Smita Tukaram Kumbhar, Shitalkumar Shivgonda Patil, Manish Sudesh Bhatia in Journal of Pharmaceutical Innovation
    Article 28 July 2021
  7. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites

    Introduction

    Metoprolol succinate is a long-acting beta-blocker prescribed for the management of hypertension (HTN) and other cardiovascular diseases....

    Chad N. Brocker, Thomas Velenosi, ... Andrew A. Monte in Human Genomics
    Article Open access 11 March 2020
  8. Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea

    Obstructive sleep apnea (OSA) is closely associated with central nervous system diseases and could lead to autonomic nerve dysfunction, which is...

    Lin Yang, **g Zhao, ... **g Ai in Acta Pharmacologica Sinica
    Article 20 December 2019
  9. Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction – a prospective observational study

    Purpose

    The β-1 adrenergic receptor blocker metoprolol is primarily metabolized by the polymorphic enzyme cytochrome P 450 2D6 (CYP2D6), an enzyme...

    Anne Kristine Anstensrud, Espen Molden, ... Erik Øie in European Journal of Clinical Pharmacology
    Article 15 January 2020
  10. Characterization of critical parameters using an air–liquid interface model with RPMI 2650 cells for permeability studies of small molecules

    The field of nasal drug delivery gained enormously on interest over the past decade. Performing nasal in vivo studies is expensive and...

    Lea-Adriana Barlang, Kristina Weinbender, ... Andreas Popp in Drug Delivery and Translational Research
    Article 17 November 2023
  11. Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis

    Analysis of illicit drugs, medicines, and pathogens in wastewater is a powerful tool for epidemiological studies to monitor public health trends. The...

    Reinhard Oertel, Sara Schubert, ... Bertold Renner in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 12 January 2023
  12. β1- and β12-adrenergic receptor antagonists block 6-nitrodopamine-induced contractions of the rat isolated epididymal vas deferens

    6-Nitrodopamine (6-ND) is an endogenous modulator of the contractility in the rat isolated epididymal vas deferens (RIEVD) and considered to be the...

    Antonio Tiago Lima, Amanda Consulin Amorim, ... Gilberto De Nucci in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 July 2022
  13. The role of the peripheral and central adrenergic system in the construction of the subjective emotional experience of panic

    Rationale

    Although the study of emotions can look back to over 100 years of research, it is unclear which information the brain uses to construct the...

    Jette H. de Vos, Koen R. J. Schruers, ... Nicole K. Leibold in Psychopharmacology
    Article Open access 16 February 2024
  14. The role of beta-adrenoreceptors in postoperative ileus in rats

    The aim of the research was to evaluate the influence of antagonists of specific beta-adrenergic receptor subtypes on bowel motility following...

    Bitel Marcin, Sztormowska-Achranowicz Katarzyna, Kocić Ivan in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 29 December 2023
  15. Effects of prophylactic antibiotics administration on barrier properties of intestinal mucosa and mucus from preterm born piglets

    Early intervention and short-duration treatments with antibiotics in premature infants are reported to reduce the incidence of necrotizing...

    Janni Støvring Mortensen, Duc Ninh Nguyen, ... Stine Rønholt in Drug Delivery and Translational Research
    Article 08 March 2023
  16. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases

    Cardiovascular diseases are the leading cause of morbidity and mortality worldwide. Effective medications for the treatment of cardiovascular...
    Living reference work entry 2023
  17. Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17

    Background

    Diabetes Mellitus (DM) is a prominent health care issue worldwide. One of the most prevalent comorbidities of DM is cardiovascular disease...

    Negin Hatami, Mohammad-Reza Malekpour, ... Fatemeh Soleymani in DARU Journal of Pharmaceutical Sciences
    Article 17 October 2023
  18. Adrenergic Receptors in the Mechanism of Regulation of Mitochondrial and Cytoplasmic Enzymes of Cardiomyocytes by Catecholamines

    We studied the role of adrenoceptors in the regulation of activity of mitochondrial and cytoplasmic enzymes in cardiomyocytes by catecholamines and...

    S. O. Tapbergenov, B. S. Sovetov, Zh. K. Smailova in Bulletin of Experimental Biology and Medicine
    Article 19 July 2022
  19. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    The main objective was to compare the meaning of soluble angiotensin-converting enzyme-2 (sACE2) plasma levels modulation on the prognosis of two...

    Cristina Almengló, Marinela Couselo-Seijas, ... Ezequiel Álvarez in Journal of Molecular Medicine
    Article 16 September 2021
  20. Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report

    Background

    Ipilimumab (Ipi) plus nivolumab (Nivo) is the recommended first-line treatment for renal cell carcinoma (RCC). This report describes a case...

    Ryo Takada, Miki Fujiwara, ... Koji Tamura in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 31 May 2024
Did you find what you were looking for? Share feedback.